CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 219 filers reported holding CANTEL MEDICAL CORP in Q1 2017. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,069,000 | -5.8% | 14,296 | +1.5% | 0.08% | 0.0% |
| Q2 2019 | $1,135,000 | +20.5% | 14,079 | 0.0% | 0.08% | +17.4% |
| Q1 2019 | $942,000 | -99.9% | 14,079 | 0.0% | 0.07% | -18.8% |
| Q4 2018 | $1,048,182,000 | -42.8% | 14,079 | -29.3% | 0.08% | -28.0% |
| Q3 2018 | $1,832,638,000 | -77.3% | 19,907 | -75.7% | 0.12% | -79.8% |
| Q2 2018 | $8,064,045,000 | -48.0% | 81,985 | -41.1% | 0.58% | -49.9% |
| Q1 2018 | $15,520,304,000 | +375.5% | 139,308 | +339.1% | 1.16% | +357.9% |
| Q4 2017 | $3,263,757,000 | +340.0% | 31,727 | +302.8% | 0.25% | +303.2% |
| Q3 2017 | $741,777,000 | +28.5% | 7,877 | +6.3% | 0.06% | +18.9% |
| Q2 2017 | $577,157,000 | +55.1% | 7,408 | +59.5% | 0.05% | +43.2% |
| Q1 2017 | $372,065,000 | +23.6% | 4,645 | +6.0% | 0.04% | -9.8% |
| Q2 2016 | $301,106,000 | -68.8% | 4,381 | -67.6% | 0.04% | -69.6% |
| Q1 2016 | $963,645,000 | +82.1% | 13,504 | +58.6% | 0.14% | +70.9% |
| Q4 2015 | $529,122,000 | – | 8,515 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DIKER MANAGEMENT LLC | 1,028,295 | $45,183,000 | 28.17% |
| NexWave Capital Partners LLC | 84,802 | $3,751,000 | 6.00% |
| Leonard Green & Partners, L.P. | 2,600,000 | $114,244,000 | 5.94% |
| Champlain Investment Partners, LLC | 3,935,670 | $172,933,000 | 1.18% |
| Aurora Investment Counsel | 19,848 | $1,137,000 | 0.94% |
| Brown Capital Management | 2,531,558 | $111,237,000 | 0.92% |
| Advantage Alpha Capital Partners LP | 73,615 | $3,235,000 | 0.75% |
| Conestoga Capital Advisors, LLC | 789,154 | $34,675,000 | 0.70% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 11,000 | $483,000 | 0.50% |
| Intrinsic Edge Capital Management LLC | 151,077 | $6,638,000 | 0.45% |